The Department of Health and Human Services National Institutes of Health (NIH) has released a Funding Opportunity Announcement (FOA) to support the development of digital therapeutics (DTx) to treat substance use disorders (SUD). DTx may include clinical-grade mobile, web, or other software-based platforms designed to deliver safe and effective SUD treatment (e.g., improving medication adherence, treatment of withdrawal, etc.). DTx are available 24/7, do not require transportation, and are not limited by clinician time, so that interventions are accessible and highly reproducible.
SPG’s summary can be found here, while the full FOA is available here. Applications for the first round are due on September 8th, with additional application rounds accepted through 2024 as outlined in the FOA.